Cetera Investment Advisers
IHE icon

Cetera Investment Advisers’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Cetera Investment Advisers’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Sell
19,565
-89,906
-82% -$8.1M ﹤0.01% 2408
2026
Q1 		$9.49M Buy
109,471
+95,353
+675% +$8.35M 0.01% 1094
2025
Q4 		$1.2M Buy
14,118
+1,039
+8% +$82.9K ﹤0.01% 2669
2025
Q3 		$949K Sell
13,079
-141
-1% -$9.73K ﹤0.01% 2811
2025
Q2 		$866K Buy
13,220
+1,505
+13% +$98K ﹤0.01% 2507
2025
Q1 		$827K Sell
11,715
-133
-1% -$9.24K ﹤0.01% 2418
2024
Q4 		$779K Sell
11,848
-145
-1% -$9.98K ﹤0.01% 2341
2024
Q3 		$847K Buy
11,993
+686
+6% +$47.8K ﹤0.01% 2239
2024
Q2 		$750K Sell
11,307
-808
-7% -$52.9K ﹤0.01% 2281
2024
Q1 		$823K Buy
+12,115
New +$801K ﹤0.01% 2228
2023
Q4 		– Sell
-3,957
Closed -$233K – 2288
2023
Q3 		$233K Sell
3,957
-66
-2% -$4.05K ﹤0.01% 1883
2023
Q2 		$240K Hold
4,023
– – ﹤0.01% 1878
2023
Q1 		$235K Buy
4,023
+72
+2% +$4.34K ﹤0.01% 1850
2022
Q4 		$245K Buy
3,951
+300
+8% +$18K ﹤0.01% 1783
2022
Q3 		$206K Sell
3,651
-345
-9% -$21.3K ﹤0.01% 1488
2022
Q2 		$255K Sell
3,996
-45
-1% -$2.86K ﹤0.01% 1526
2022
Q1 		$262K Sell
4,041
-264
-6% -$16.7K ﹤0.01% 1555
2021
Q4 		$286K Sell
4,305
-21
-0.5% -$1.33K ﹤0.01% 1518
2021
Q3 		$264K Sell
4,326
-1,056
-20% -$67.1K ﹤0.01% 1519
2021
Q2 		$333K Sell
5,382
-30
-0.6% -$1.82K 0.01% 1350
2021
Q1 		$320K Buy
5,412
+93
+2% +$5.61K 0.01% 1226
2020
Q4 		$318K Buy
+5,319
New +$303K 0.01% 1206

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Cetera Investment Advisers's IHE Position: Q2 2026 in Review

Cetera Investment Advisers reduced its iShares US Pharmaceuticals ETF (IHE) stake by 82% in Q2 2026, selling an estimated $8.1M and leaving 19,565 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2408.

Cetera Investment Advisers first reported a position in IHE in Q4 2020 and has held it in 22 quarters since. The position peaked at $9.49M in Q1 2026. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Cetera Investment Advisers held 19,565 shares of iShares US Pharmaceuticals ETF worth $1.94M as of Q2 2026.
  • Cetera Investment Advisers sold 89,906 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $8.1M.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2408 holding.
  • Cetera Investment Advisers first reported a position in iShares US Pharmaceuticals ETF in Q4 2020 and has held it in 22 quarters since.
  • Cetera Investment Advisers's iShares US Pharmaceuticals ETF position peaked at $9.49M in Q1 2026.
  • 209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.